These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28035945)

  • 1. Design and Biological Evaluation of Delivery Systems Containing Bisphosphonates.
    Aderibigbe B; Aderibigbe I; Popoola P
    Pharmaceutics; 2016 Dec; 9(1):. PubMed ID: 28035945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of delivery system of bisphosphonates for the treatment of osteoporosis].
    Katsumi H; Kusamori K; Sakane T; Yamamoto A
    Yakugaku Zasshi; 2010 Sep; 130(9):1129-33. PubMed ID: 20823670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry, pharmacokinetics, pharmacology and recent novel drug delivery systems of paeonol.
    Adki KM; Kulkarni YA
    Life Sci; 2020 Jun; 250():117544. PubMed ID: 32179072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revitalizing allicin for cancer therapy: advances in formulation strategies to enhance bioavailability, stability, and clinical efficacy.
    Bala R; Madaan R; Chauhan S; Gupta M; Dubey AK; Zahoor I; Brijesh H; Calina D; Sharifi-Rad J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; 397(2):703-724. PubMed ID: 37615709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A colloidal hydrogel-based drug delivery system overcomes the limitation of combining bisphosphonates with bioactive glasses: in vitro evidence of a potential selective bone cancer treatment allied with bone regeneration.
    Borges R; Zambanini T; Pelosine AM; Justo GZ; Souza ACS; Machado J; Schneider JF; de Araujo DR; Marchi J
    Biomater Adv; 2023 Aug; 151():213441. PubMed ID: 37167747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Re-Packaging of Bisphosphonates Using Biomaterials.
    Barik D; Dash P; Uma PI; Kumari S; Dash M
    J Pharm Sci; 2021 Dec; 110(12):3757-3772. PubMed ID: 34474062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer.
    Haggag YA; Ibrahim RR; Hafiz AA
    Int J Nanomedicine; 2020; 15():1625-1642. PubMed ID: 32210557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs.
    Alven S; Aderibigbe BA
    Nanomaterials (Basel); 2020 Aug; 10(8):. PubMed ID: 32784356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving drug biological effects by encapsulation into polymeric nanocapsules.
    Frank LA; Contri RV; Beck RC; Pohlmann AR; Guterres SS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(5):623-39. PubMed ID: 25641603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates and other bone agents for breast cancer.
    O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates as a foundation of drug delivery to bone.
    Uludag H
    Curr Pharm Des; 2002; 8(21):1929-44. PubMed ID: 12171528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-Responsive Boron-Based Materials in Drug Delivery.
    Das BC; Chokkalingam P; Masilamani P; Shukla S; Das S
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles Formulations of Artemisinin and Derivatives as Potential Therapeutics for the Treatment of Cancer, Leishmaniasis and Malaria.
    Alven S; Aderibigbe BA
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32784933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates: focus on inflammation and bone loss.
    Iannitti T; Rosini S; Lodi D; Frediani B; Rottigni V; Palmieri B
    Am J Ther; 2012 May; 19(3):228-46. PubMed ID: 22549638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomedical applications of bisphosphonates.
    Giger EV; Castagner B; Leroux JC
    J Control Release; 2013 Apr; 167(2):175-88. PubMed ID: 23395668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates as treatment of bone metastases.
    Holen I; Coleman RE
    Curr Pharm Des; 2010; 16(11):1262-71. PubMed ID: 20166976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the anti-tumour activity of bisphosphonates in early breast cancer.
    Winter MC; Holen I; Coleman RE
    Cancer Treat Rev; 2008 Aug; 34(5):453-75. PubMed ID: 18423992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-scale drug delivery systems for luteolin: advancements and applications.
    Shang J; Yang J; Deng Q; Zhou M
    J Mater Chem B; 2023 Dec; 11(47):11198-11216. PubMed ID: 37986608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.